Anti-Cancer Drugs


ISSN: 0959-4973        年代:2002
当前卷期:Volume 13  issue 5     [ 查看所有卷期 ]

年代:2002
 
     Volume 13  issue 1   
     Volume 13  issue 2   
     Volume 13  issue 3   
     Volume 13  issue 4   
     Volume 13  issue 5
     Volume 13  issue 6   
     Volume 13  issue 7   
     Volume 13  issue 8   
     Volume 13  issue 9   
     Volume 13  issue 10   
1. First International SymposiumVitamin D Analogs in Cancer Prevention and Therapy
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  1-24

Preview

2. A3 adenosine receptor as a target for cancer therapy
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  437-443

Pnina Fishman,   Sara Bar-Yehuda,   Lea Madi,   Ilan Cohn,  

Preview   |   PDF (339KB)

3. Acronycine derivatives as promising antitumor agents
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  445-449

Nicolas Guilbaud,   Stéphane Léonce,   François Tillequin,   Michel Koch,   John Hickman,   Alain Pierré,  

Preview   |   PDF (89KB)

4. Docetaxel in advanced gastric cancer
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  451-460

Daniel Haller,   Jean-Louis Misset,  

Preview   |   PDF (123KB)

5. Advanced colorectal cancer treatment in Europe: what have we achieved?
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  461-471

Harry Bleiberg,   Alain Hendlisz,  

Preview   |   PDF (157KB)

6. A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  473-480

Amélie Gauvin,   Frédéric Pinguet,   Stéphane Culine,   Cécile Astre,   Roberto Gomeni,   Françoise Bressolle,  

Preview   |   PDF (147KB)

7. Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  481-489

Evangelos Briasoulis,   Vasilis Karavasilis,   Eleftheria Tzamakou,   Constantina Haidou,   Christina Piperidou,   Nicholas Pavlidis,  

Preview   |   PDF (127KB)

8. Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  491-495

Claudia Gedlicka,   Birgit Schüll,   Michael Formanek,   Johannes Kornfehl,   Martin Burian,   Birgit Knerer,   Edgar Selzer,   Werner Scheithauer,   Gabriela Kornek,  

Preview   |   PDF (84KB)

9. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  497-503

F Honecker,   C Kollmannsberger,   D Quietzsch,   C Haag,   M Schroeder,   C Spott,   JT Hartmann,   W Baronius,   V Hempel,   L Kanz,   C Bokemeyer,  

Preview   |   PDF (99KB)

10. Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer
  Anti-Cancer Drugs,   Volume  13,   Issue  5,   2002,   Page  505-509

Akihisa Fujita,   Toshihiko Ohkubo,   Hideaki Hoshino,   Hirotsugu Takabatake,   Shigeru Tagaki,   Kyuhichiro Sekine,  

Preview   |   PDF (81KB)

首页 上一页 下一页 尾页 第1页 共13条